Evidence map›Paper›PMID 25309630›Full record

ArticleAnimal reproduction2013

Testisimmune privilege - Assumptions

G Kaur, P Mital, J M Dufour

Open access · greenAbstract read
In one paragraph

Article in Animal reproduction, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Immunologic Environment of the Testis.Advances in experimental medicine and biology · 2021
    Article
  15. Review
  16. Review
  17. Growing Trans-Species Islets in Tumor Extract-Remodeled Testicles.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

G KaurDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
P MitalDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
J M DufourDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Texas Tech University · USTexas Tech University Health Sciences Center · US

Funding

Transplantation of Genetically Modified, Immune-privileged Steroli CellsR01HD067400 · NICHD · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI DUFOUR, JANNETTE M · 2010 to 2012
$663k
NICHD NIH HHS R01 HD067400
6 · The paper itself

Abstract

The testis has long enjoyed a reputation as an immunologically privileged site based on its ability to protect auto-antigenic germ cells and provide an optimal environment for the extended survival of transplanted allo- or xeno-grafts. Exploration of the role of anatomical, physiological, immunological and cellular components in testis immune privilege revealed that the tolerogenic environment of the testis is a result of the immunomodulatory factors expressed or secreted by testicular cells (mainly Sertoli cells, peritubular myoid cells, Leydig cells, and resident macrophages). The blood-testis barrier/Sertoli cell barrier, is also important to seclude advanced germ cells but its requirement in testis immune privilege needs further investigation. Testicular immune privilege is not permanent, as an effective immune response can be mounted against transplanted tissue, and bacterial/viral infections in the testis can be effectively eliminated. Overall, the cellular components control the fate of the immune response and can shift the response from immunodestructive to immunoprotective, resulting in immune privilege.

Indexed as

immune privilegetestistransplantation

Identifiers

PMID25309630
PMCPMC4192663
OpenAlexW2462315244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.